
4 Biotech Stocks to Keep an Eye on in 2023
Despite rising borrowing costs, slowing aggregate demand, and looming recession fears, the U.S. GDP rose 2.9% annually in the fourth quarter of 2022, beating consensus estimates. This has instilled significant optimism among investors. Moreover, the …